Skip NavigationSkip to Content

Variation in KSHV prevalence between geographically proximate locations in Uganda

  1. Author:
    Nalwoga, Angela [ORCID]
    Webb, Emily L
    Muserere, Claudios
    Chihota, Belinda
    Miley,Wendell
    Labo,Nazzarena
    Elliott, Alison
    Cose, Stephen
    Whitby,Denise
    Newton, Robert
  2. Author Address

    MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda., Department of Immunology and Microbiology, University of Colorado, Anschutz Medical Campus, Aurora, CO USA., London School of Hygiene & Tropical Medicine, London, UK., Viral Oncology Section, AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD USA., University of York, York, UK.,
    1. Year: 2020
    2. Date: JUL 23
    3. Epub Date: 2020 07 23
  1. Journal: Infectious agents and cancer
    1. 15
    2. Pages: 49
  2. Type of Article: Article
  3. Article Number: 49
  4. ISSN: 1750-9378
  1. Abstract:

    Kaposi's sarcoma-associated herpesvirus (KSHV) transmission within endemic areas may vary. KSHV seroprevalence has been studied by different groups of researchers using different methods, making it difficult to make direct comparisons. Here we show results on KSHV seroprevalence using the same laboratory method from four different but geographically proximate populations in Uganda. Blood samples from the urban Entebbe Mother and Baby Study (EMaBS), the rural General Population Cohort (GPC), the fishing community Lake Victoria Island Intervention Study on Worms and Allergy related Diseases (LaVIISWA) and the high-risk sexual behaviour Good Health for Women Project (GHWP), were tested for IgG antibody levels to K8.1 and ORF73 recombinant proteins using ELISA. All adult participants of the EMaBS study and the GHWP were women, while the GPC (54% female) and LaVIISWA (52% female) studies had both males and females. EMaBS children were all 5?years of age while their mothers were 14 to 47?years of age. GHWP women were 15 to 45?years old, LaVIISWA participants were 1 to 72?years old while GPC participants were 1 to 103?years old. KSHV seropositivity varied in the different populations. In children aged 5?years, EMaBS had the lowest prevalence of 15% followed by GPC at 35% and LaVIISWA at 54%. In adult women, seropositivity varied from 69% (EMaBS) to 80% (LaVIISWA) to 87% (GPC) to 90% (GHWP). The reasons for the variation in prevalence are unclear but may reflect differences in the prevalence of cofactors between these four geographically proximate populations. © The Author(s) 2020.

    See More

External Sources

  1. DOI: 10.1186/s13027-020-00313-8
  2. PMID: 32714434
  3. PMCID: PMC7376633
  4. WOS: 000555753500001
  5. PII : 313

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel